SlideShare a Scribd company logo
1 of 16
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 1
Third International Conference for Improving Use of
Medicines (ICIUM2011):
Informed Strategies, Effective Policies, Lasting Solutions
Bibliotheca Alexandrina
April 10th-14th 2011
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 2
WHO Eastern Mediterranean Region
22 countries
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 3
Introduction
 The diversity in the region hinders any regional generalization.
 Contexts are markedly different and so are the priorities.
 A low income country – Pakistan – has a sizeable pharmaceutical
industrial base.
 A highest income country – Qatar – does not have any
pharmaceutical company.
 A lower middle income country – Jordan – has an FDA with a more
than 400 staff.
 An upper middle income country – Libya – has almost negligible
regulatory capacity
Pharmaceutical Context & Priorities
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 4
Classification of EMR countries by income
(World bank 2009)
High-income Upper-middle-income
Bahrain
Kuwait
Oman
Qatar
Saudi Arabia
UAE
Lebanon
Libya
Lower-middle-income Low-income
Djibouti
Egypt
Iran, Islamic Republic
Iraq
Jordan
Morocco
Pakistan
Palestine
Sudan
Syrian Arab Republic
Tunisia
Afghanistan
Somalia
Yemen
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 5
Analytical Matrix
W M S
Medicine Policy
Access
Quality -
Regulation
Rational Use
Pharmaceutical Context & Priorities
Low
Income
Countries
Lower M
Income
Countries
Upper M
Income
Countries
High
Income
Countries
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 6
Expenditure on medicines
from 9 NHA studies in the Region
■ 40% of total health expenditure is on medicines
■ Up to 30% of the budget of ministries of health is spent on
medicines
■ Out-of-pocket expenditure is high
 Egypt: 53% of all medicines are purchased directly by
households
 Morocco: 74%
Pharmaceutical Context & Priorities
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 7
ICIUM Conferences
Goals:
•Assemble the state-of-the-art knowledge about
ways to improve medicines use and health,
especially for the most vulnerable populations
•Recommend evidence-based strategies for
improving use at different levels in the health
care system
•Identify ways to monitor and evaluate policy
impacts
•Develop a research agenda to further knowledge
about how to improve medicines use
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 8
ICIUM conferences are unique
 They focus on use of medicines in low and middle income countries
 They are highly interactive
 They produce actionable results
 ICIUM 1997 and 2004 proceedings available at www.icium.org
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 9
Partners Supporting ICIUM 2011
•International Network for Rational Use of Drugs
•World Health Organization
•Eastern Mediterranean Regional Office
•Department of Essential Medicines and
Pharmaceutical Policies
•Harvard Medical School and Boston University
School of Public Health: WHO Collaborating Center in
Pharmaceutical Policy
•Karloniska Institute, Division of Global Health
•Management Sciences for Health, Strengthening
Pharmaceutical Systems
•University of Alexandria
•Bibliotheca Alexandrina
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 10
Conference Structure: Focus Areas
 Conference discussions will focus on each on the following
levels in health care systems where changes to improve
medicines use take place:
Global
National
Institutional and
Individual (health care providers and consumers, including
community systems)
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 11
Conference Structure: Topic Track Objectives
•To cover major areas of clinical and programmatic interest related
to pharmaceuticals in low and middle income countries
• To encourage cross-fertilization of ideas by having participants
from different topic areas
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 12
Conference Structure: Provisional Topic Tracks
 Access (policy, regulation, governance)
 HIV/AIDS, TB
 Malaria
 Maternal and child health (IMCI, pediatric medicines)
 Chronic care (diabetes, hypertension, mental health,
information technology for adherence)
 Drug resistance (surveillance, containment strategies, drug
development)
 Economics, financing, insurance systems (cost, affordability,
incentives, medicines coverage, policy options, impacts)
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 13
ICIUM 2011 Participants
 Each of the 500 or so participant of ICIUM2011 will be
expected to play an active role in the conference.
 Those with submitted abstracts are much more likely to
be accepted.
 ICIUM 2004 had 472 participants from 70 countries.
There were 299 presentations and 326 posters.
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 14
ICIUM 2011 Registration and Abstract Submission
 Details of how to register and how to submit abstracts
are posted on the ICIUM 2011 website www.icium.org
 Abstracts must be submitted by 7 December 2010.
 Each abstract will be peer reviewed. If improvements
are needed authors will be mentored.
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 15
Essential Medicines and Pharmaceutical Policies Unit
Sept 2010– ICIUM 2011 16
Thank you
See you April 10th-14th 2011 in the Bibliotheca Alexandria
Watch www.icium.org for more information

More Related Content

What's hot

Health Care and Diagnostics Sector Saudi Arabia - Opportunity Arabia 11, 2014
Health Care and Diagnostics Sector Saudi Arabia - Opportunity Arabia 11, 2014Health Care and Diagnostics Sector Saudi Arabia - Opportunity Arabia 11, 2014
Health Care and Diagnostics Sector Saudi Arabia - Opportunity Arabia 11, 2014Odyssey Recruitment
 
Moroccan medical device market
Moroccan medical device marketMoroccan medical device market
Moroccan medical device marketBusiness Finland
 
Obama care a new opportunity in us healthcare - finpro
Obama care   a new opportunity in us healthcare - finproObama care   a new opportunity in us healthcare - finpro
Obama care a new opportunity in us healthcare - finproBusiness Finland
 
Joint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceJoint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceDutch Orphan Drug Network
 
Oncology Drugs: The journey From Manufacturer To The End User
Oncology Drugs: The journey From Manufacturer To The End UserOncology Drugs: The journey From Manufacturer To The End User
Oncology Drugs: The journey From Manufacturer To The End UserPharmacy @ Institut Kanser Negara
 
Concept and structure of MeTA
Concept and structure of MeTAConcept and structure of MeTA
Concept and structure of MeTAMeTApresents
 
ExportKorea(Jin, 2014)
ExportKorea(Jin, 2014)ExportKorea(Jin, 2014)
ExportKorea(Jin, 2014)Ki Nam Jin
 
African Medicines Regulatory Harmonisation
African Medicines Regulatory Harmonisation African Medicines Regulatory Harmonisation
African Medicines Regulatory Harmonisation PharmaAfrica
 
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
Drug Approval Bodies in Canada 101: The Elevator Length PitchDrug Approval Bodies in Canada 101: The Elevator Length Pitch
Drug Approval Bodies in Canada 101: The Elevator Length PitchCanadian Cancer Survivor Network
 
Medicines Use and Spending Shifts: A Review of the Use of Medicines
Medicines Use and Spending Shifts: A Review of the Use of MedicinesMedicines Use and Spending Shifts: A Review of the Use of Medicines
Medicines Use and Spending Shifts: A Review of the Use of MedicinesIMS Health US
 
Medical Devices Market Overview and Degree 36 First Impression
Medical Devices Market Overview and Degree 36 First ImpressionMedical Devices Market Overview and Degree 36 First Impression
Medical Devices Market Overview and Degree 36 First ImpressionIpsos Business Consulting
 
STREAM TWO: Fiona Frappier, Canada’s regulatory approach to drugs for rare di...
STREAM TWO: Fiona Frappier, Canada’s regulatory approach to drugs for rare di...STREAM TWO: Fiona Frappier, Canada’s regulatory approach to drugs for rare di...
STREAM TWO: Fiona Frappier, Canada’s regulatory approach to drugs for rare di...Canadian Organization for Rare Disorders
 
Identifying Opportunities Within ASEAN's Universal Healthcare Programmes
Identifying Opportunities Within ASEAN's Universal Healthcare ProgrammesIdentifying Opportunities Within ASEAN's Universal Healthcare Programmes
Identifying Opportunities Within ASEAN's Universal Healthcare ProgrammesIpsos Business Consulting
 
Iihi us use_of_meds_for_2013
Iihi us use_of_meds_for_2013Iihi us use_of_meds_for_2013
Iihi us use_of_meds_for_2013Georgi Daskalov
 
Pharmacovigilance in the Middle East
Pharmacovigilance in the Middle EastPharmacovigilance in the Middle East
Pharmacovigilance in the Middle EastAmjád Atrásh
 
Medicines Transparency Alliance (MeTA) Jordan
Medicines Transparency Alliance (MeTA) JordanMedicines Transparency Alliance (MeTA) Jordan
Medicines Transparency Alliance (MeTA) JordanMeTApresents
 

What's hot (20)

Health Care and Diagnostics Sector Saudi Arabia - Opportunity Arabia 11, 2014
Health Care and Diagnostics Sector Saudi Arabia - Opportunity Arabia 11, 2014Health Care and Diagnostics Sector Saudi Arabia - Opportunity Arabia 11, 2014
Health Care and Diagnostics Sector Saudi Arabia - Opportunity Arabia 11, 2014
 
Moroccan medical device market
Moroccan medical device marketMoroccan medical device market
Moroccan medical device market
 
Obama care a new opportunity in us healthcare - finpro
Obama care   a new opportunity in us healthcare - finproObama care   a new opportunity in us healthcare - finpro
Obama care a new opportunity in us healthcare - finpro
 
Joint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceJoint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task Force
 
Oncology Drugs: The journey From Manufacturer To The End User
Oncology Drugs: The journey From Manufacturer To The End UserOncology Drugs: The journey From Manufacturer To The End User
Oncology Drugs: The journey From Manufacturer To The End User
 
Concept and structure of MeTA
Concept and structure of MeTAConcept and structure of MeTA
Concept and structure of MeTA
 
ExportKorea(Jin, 2014)
ExportKorea(Jin, 2014)ExportKorea(Jin, 2014)
ExportKorea(Jin, 2014)
 
African Medicines Regulatory Harmonisation
African Medicines Regulatory Harmonisation African Medicines Regulatory Harmonisation
African Medicines Regulatory Harmonisation
 
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
Drug Approval Bodies in Canada 101: The Elevator Length PitchDrug Approval Bodies in Canada 101: The Elevator Length Pitch
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
 
Medicines Use and Spending Shifts: A Review of the Use of Medicines
Medicines Use and Spending Shifts: A Review of the Use of MedicinesMedicines Use and Spending Shifts: A Review of the Use of Medicines
Medicines Use and Spending Shifts: A Review of the Use of Medicines
 
National Drug Policy
National Drug Policy National Drug Policy
National Drug Policy
 
Medical Devices Market Overview and Degree 36 First Impression
Medical Devices Market Overview and Degree 36 First ImpressionMedical Devices Market Overview and Degree 36 First Impression
Medical Devices Market Overview and Degree 36 First Impression
 
STREAM TWO: Fiona Frappier, Canada’s regulatory approach to drugs for rare di...
STREAM TWO: Fiona Frappier, Canada’s regulatory approach to drugs for rare di...STREAM TWO: Fiona Frappier, Canada’s regulatory approach to drugs for rare di...
STREAM TWO: Fiona Frappier, Canada’s regulatory approach to drugs for rare di...
 
Identifying Opportunities Within ASEAN's Universal Healthcare Programmes
Identifying Opportunities Within ASEAN's Universal Healthcare ProgrammesIdentifying Opportunities Within ASEAN's Universal Healthcare Programmes
Identifying Opportunities Within ASEAN's Universal Healthcare Programmes
 
Setting the threshold for reimbursement of a treatment
Setting the threshold for reimbursement of a treatmentSetting the threshold for reimbursement of a treatment
Setting the threshold for reimbursement of a treatment
 
Iihi us use_of_meds_for_2013
Iihi us use_of_meds_for_2013Iihi us use_of_meds_for_2013
Iihi us use_of_meds_for_2013
 
Pharmacovigilance in the Middle East
Pharmacovigilance in the Middle EastPharmacovigilance in the Middle East
Pharmacovigilance in the Middle East
 
Dental directory
Dental directoryDental directory
Dental directory
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Medicines Transparency Alliance (MeTA) Jordan
Medicines Transparency Alliance (MeTA) JordanMedicines Transparency Alliance (MeTA) Jordan
Medicines Transparency Alliance (MeTA) Jordan
 

Similar to ICIUM 2011

Increasing access to medicines
Increasing access to medicinesIncreasing access to medicines
Increasing access to medicinesMeTApresents
 
alliancehpsr_lebanon_atmps
alliancehpsr_lebanon_atmpsalliancehpsr_lebanon_atmps
alliancehpsr_lebanon_atmpsRawan Chaaban
 
Problems and challenges faced in consumer reporting of adverse drug reactions...
Problems and challenges faced in consumer reporting of adverse drug reactions...Problems and challenges faced in consumer reporting of adverse drug reactions...
Problems and challenges faced in consumer reporting of adverse drug reactions...Mohammed Alshakka
 
report-building-platform-gpp-macedonia
report-building-platform-gpp-macedoniareport-building-platform-gpp-macedonia
report-building-platform-gpp-macedoniaJasminka Patceva
 
Orphan Drugs – High Prices: Is there a Way Forward?
Orphan Drugs – High Prices: Is there a Way Forward?Orphan Drugs – High Prices: Is there a Way Forward?
Orphan Drugs – High Prices: Is there a Way Forward?Office of Health Economics
 
WHO Guideline of Medicine Policy.pdf
WHO Guideline of Medicine Policy.pdfWHO Guideline of Medicine Policy.pdf
WHO Guideline of Medicine Policy.pdfPurbanchal University
 
The Integration of Traditional and Complementary Medicine in Health Systems 2012
The Integration of Traditional and Complementary Medicine in Health Systems 2012The Integration of Traditional and Complementary Medicine in Health Systems 2012
The Integration of Traditional and Complementary Medicine in Health Systems 2012Asian Food Regulation Information Service
 
Presentation for EPEMED Webinar (11-27-12) Final
Presentation for EPEMED Webinar (11-27-12) FinalPresentation for EPEMED Webinar (11-27-12) Final
Presentation for EPEMED Webinar (11-27-12) FinalStig Albinus
 
The Role of Pharmacovigilance in Ensuring Drug Safety and Efficacy
The Role of Pharmacovigilance in Ensuring Drug Safety and EfficacyThe Role of Pharmacovigilance in Ensuring Drug Safety and Efficacy
The Role of Pharmacovigilance in Ensuring Drug Safety and EfficacyClinosolIndia
 
Edmondo Aimee PHA Final Spring 2014
Edmondo Aimee PHA Final Spring 2014Edmondo Aimee PHA Final Spring 2014
Edmondo Aimee PHA Final Spring 2014Aimee Edmondo
 
Minimum requirements for a functional pharmacovigilance system
Minimum requirements for a functional pharmacovigilance systemMinimum requirements for a functional pharmacovigilance system
Minimum requirements for a functional pharmacovigilance systemPriti Gupta
 
Does Price Discrimination Have a Place in Pharmaceutical Pricing in Developin...
Does Price Discrimination Have a Place in Pharmaceutical Pricing in Developin...Does Price Discrimination Have a Place in Pharmaceutical Pricing in Developin...
Does Price Discrimination Have a Place in Pharmaceutical Pricing in Developin...Office of Health Economics
 
The data and analytics of the new life sciences marketplace handout
The data and analytics of the new life sciences marketplace handoutThe data and analytics of the new life sciences marketplace handout
The data and analytics of the new life sciences marketplace handoutFrank Wartenberg
 
Planning the Development of the Singapore National Health Portal [4 Cr3 1330 ...
Planning the Development of the Singapore National Health Portal [4 Cr3 1330 ...Planning the Development of the Singapore National Health Portal [4 Cr3 1330 ...
Planning the Development of the Singapore National Health Portal [4 Cr3 1330 ...Gunther Eysenbach
 

Similar to ICIUM 2011 (20)

Pharmacovigilance: Partnering for Patient Safety
Pharmacovigilance: Partnering for Patient SafetyPharmacovigilance: Partnering for Patient Safety
Pharmacovigilance: Partnering for Patient Safety
 
Increasing access to medicines
Increasing access to medicinesIncreasing access to medicines
Increasing access to medicines
 
alliancehpsr_lebanon_atmps
alliancehpsr_lebanon_atmpsalliancehpsr_lebanon_atmps
alliancehpsr_lebanon_atmps
 
Problems and challenges faced in consumer reporting of adverse drug reactions...
Problems and challenges faced in consumer reporting of adverse drug reactions...Problems and challenges faced in consumer reporting of adverse drug reactions...
Problems and challenges faced in consumer reporting of adverse drug reactions...
 
report-building-platform-gpp-macedonia
report-building-platform-gpp-macedoniareport-building-platform-gpp-macedonia
report-building-platform-gpp-macedonia
 
Orphan Drugs – High Prices: Is there a Way Forward?
Orphan Drugs – High Prices: Is there a Way Forward?Orphan Drugs – High Prices: Is there a Way Forward?
Orphan Drugs – High Prices: Is there a Way Forward?
 
Essential medicine
Essential medicineEssential medicine
Essential medicine
 
WHO Guideline of Medicine Policy.pdf
WHO Guideline of Medicine Policy.pdfWHO Guideline of Medicine Policy.pdf
WHO Guideline of Medicine Policy.pdf
 
2011 national harmony in pharmacy education and training
2011   national harmony in pharmacy education and training2011   national harmony in pharmacy education and training
2011 national harmony in pharmacy education and training
 
The Integration of Traditional and Complementary Medicine in Health Systems 2012
The Integration of Traditional and Complementary Medicine in Health Systems 2012The Integration of Traditional and Complementary Medicine in Health Systems 2012
The Integration of Traditional and Complementary Medicine in Health Systems 2012
 
Presentation for EPEMED Webinar (11-27-12) Final
Presentation for EPEMED Webinar (11-27-12) FinalPresentation for EPEMED Webinar (11-27-12) Final
Presentation for EPEMED Webinar (11-27-12) Final
 
The Role of Pharmacovigilance in Ensuring Drug Safety and Efficacy
The Role of Pharmacovigilance in Ensuring Drug Safety and EfficacyThe Role of Pharmacovigilance in Ensuring Drug Safety and Efficacy
The Role of Pharmacovigilance in Ensuring Drug Safety and Efficacy
 
Drug information services by BNP.pdf
Drug information services by BNP.pdfDrug information services by BNP.pdf
Drug information services by BNP.pdf
 
Edmondo Aimee PHA Final Spring 2014
Edmondo Aimee PHA Final Spring 2014Edmondo Aimee PHA Final Spring 2014
Edmondo Aimee PHA Final Spring 2014
 
Minimum requirements for a functional pharmacovigilance system
Minimum requirements for a functional pharmacovigilance systemMinimum requirements for a functional pharmacovigilance system
Minimum requirements for a functional pharmacovigilance system
 
Does Price Discrimination Have a Place in Pharmaceutical Pricing in Developin...
Does Price Discrimination Have a Place in Pharmaceutical Pricing in Developin...Does Price Discrimination Have a Place in Pharmaceutical Pricing in Developin...
Does Price Discrimination Have a Place in Pharmaceutical Pricing in Developin...
 
The data and analytics of the new life sciences marketplace handout
The data and analytics of the new life sciences marketplace handoutThe data and analytics of the new life sciences marketplace handout
The data and analytics of the new life sciences marketplace handout
 
ABPI white paper
ABPI white paperABPI white paper
ABPI white paper
 
Ich
IchIch
Ich
 
Planning the Development of the Singapore National Health Portal [4 Cr3 1330 ...
Planning the Development of the Singapore National Health Portal [4 Cr3 1330 ...Planning the Development of the Singapore National Health Portal [4 Cr3 1330 ...
Planning the Development of the Singapore National Health Portal [4 Cr3 1330 ...
 

Recently uploaded

VIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service Jamshedpur
VIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service JamshedpurVIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service Jamshedpur
VIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service JamshedpurSuhani Kapoor
 
Vip Dewas Call Girls #9907093804 Contact Number Escorts Service Dewas
Vip Dewas Call Girls #9907093804 Contact Number Escorts Service DewasVip Dewas Call Girls #9907093804 Contact Number Escorts Service Dewas
Vip Dewas Call Girls #9907093804 Contact Number Escorts Service Dewasmakika9823
 
VIP Kolkata Call Girl Howrah 👉 8250192130 Available With Room
VIP Kolkata Call Girl Howrah 👉 8250192130  Available With RoomVIP Kolkata Call Girl Howrah 👉 8250192130  Available With Room
VIP Kolkata Call Girl Howrah 👉 8250192130 Available With Roomdivyansh0kumar0
 
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,noida100girls
 
Sales & Marketing Alignment: How to Synergize for Success
Sales & Marketing Alignment: How to Synergize for SuccessSales & Marketing Alignment: How to Synergize for Success
Sales & Marketing Alignment: How to Synergize for SuccessAggregage
 
Case study on tata clothing brand zudio in detail
Case study on tata clothing brand zudio in detailCase study on tata clothing brand zudio in detail
Case study on tata clothing brand zudio in detailAriel592675
 
/:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In...
/:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In.../:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In...
/:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In...lizamodels9
 
Call Girls In ⇛⇛Chhatarpur⇚⇚. Brings Offer Delhi Contact Us 8377877756
Call Girls In ⇛⇛Chhatarpur⇚⇚. Brings Offer Delhi Contact Us 8377877756Call Girls In ⇛⇛Chhatarpur⇚⇚. Brings Offer Delhi Contact Us 8377877756
Call Girls In ⇛⇛Chhatarpur⇚⇚. Brings Offer Delhi Contact Us 8377877756dollysharma2066
 
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...lizamodels9
 
(8264348440) 🔝 Call Girls In Hauz Khas 🔝 Delhi NCR
(8264348440) 🔝 Call Girls In Hauz Khas 🔝 Delhi NCR(8264348440) 🔝 Call Girls In Hauz Khas 🔝 Delhi NCR
(8264348440) 🔝 Call Girls In Hauz Khas 🔝 Delhi NCRsoniya singh
 
FULL ENJOY - 9953040155 Call Girls in Chhatarpur | Delhi
FULL ENJOY - 9953040155 Call Girls in Chhatarpur | DelhiFULL ENJOY - 9953040155 Call Girls in Chhatarpur | Delhi
FULL ENJOY - 9953040155 Call Girls in Chhatarpur | DelhiMalviyaNagarCallGirl
 
Non Text Magic Studio Magic Design for Presentations L&P.pptx
Non Text Magic Studio Magic Design for Presentations L&P.pptxNon Text Magic Studio Magic Design for Presentations L&P.pptx
Non Text Magic Studio Magic Design for Presentations L&P.pptxAbhayThakur200703
 
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...lizamodels9
 
Call Girls Miyapur 7001305949 all area service COD available Any Time
Call Girls Miyapur 7001305949 all area service COD available Any TimeCall Girls Miyapur 7001305949 all area service COD available Any Time
Call Girls Miyapur 7001305949 all area service COD available Any Timedelhimodelshub1
 
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...lizamodels9
 
2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis Usage2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis UsageNeil Kimberley
 
Call Girls in Mehrauli Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Mehrauli Delhi 💯Call Us 🔝8264348440🔝Call Girls in Mehrauli Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Mehrauli Delhi 💯Call Us 🔝8264348440🔝soniya singh
 

Recently uploaded (20)

VIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service Jamshedpur
VIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service JamshedpurVIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service Jamshedpur
VIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service Jamshedpur
 
Vip Dewas Call Girls #9907093804 Contact Number Escorts Service Dewas
Vip Dewas Call Girls #9907093804 Contact Number Escorts Service DewasVip Dewas Call Girls #9907093804 Contact Number Escorts Service Dewas
Vip Dewas Call Girls #9907093804 Contact Number Escorts Service Dewas
 
VIP Kolkata Call Girl Howrah 👉 8250192130 Available With Room
VIP Kolkata Call Girl Howrah 👉 8250192130  Available With RoomVIP Kolkata Call Girl Howrah 👉 8250192130  Available With Room
VIP Kolkata Call Girl Howrah 👉 8250192130 Available With Room
 
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
 
Sales & Marketing Alignment: How to Synergize for Success
Sales & Marketing Alignment: How to Synergize for SuccessSales & Marketing Alignment: How to Synergize for Success
Sales & Marketing Alignment: How to Synergize for Success
 
KestrelPro Flyer Japan IT Week 2024 (English)
KestrelPro Flyer Japan IT Week 2024 (English)KestrelPro Flyer Japan IT Week 2024 (English)
KestrelPro Flyer Japan IT Week 2024 (English)
 
Case study on tata clothing brand zudio in detail
Case study on tata clothing brand zudio in detailCase study on tata clothing brand zudio in detail
Case study on tata clothing brand zudio in detail
 
/:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In...
/:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In.../:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In...
/:Call Girls In Indirapuram Ghaziabad ➥9990211544 Independent Best Escorts In...
 
Call Girls In ⇛⇛Chhatarpur⇚⇚. Brings Offer Delhi Contact Us 8377877756
Call Girls In ⇛⇛Chhatarpur⇚⇚. Brings Offer Delhi Contact Us 8377877756Call Girls In ⇛⇛Chhatarpur⇚⇚. Brings Offer Delhi Contact Us 8377877756
Call Girls In ⇛⇛Chhatarpur⇚⇚. Brings Offer Delhi Contact Us 8377877756
 
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
 
(8264348440) 🔝 Call Girls In Hauz Khas 🔝 Delhi NCR
(8264348440) 🔝 Call Girls In Hauz Khas 🔝 Delhi NCR(8264348440) 🔝 Call Girls In Hauz Khas 🔝 Delhi NCR
(8264348440) 🔝 Call Girls In Hauz Khas 🔝 Delhi NCR
 
Best Practices for Implementing an External Recruiting Partnership
Best Practices for Implementing an External Recruiting PartnershipBest Practices for Implementing an External Recruiting Partnership
Best Practices for Implementing an External Recruiting Partnership
 
FULL ENJOY - 9953040155 Call Girls in Chhatarpur | Delhi
FULL ENJOY - 9953040155 Call Girls in Chhatarpur | DelhiFULL ENJOY - 9953040155 Call Girls in Chhatarpur | Delhi
FULL ENJOY - 9953040155 Call Girls in Chhatarpur | Delhi
 
Non Text Magic Studio Magic Design for Presentations L&P.pptx
Non Text Magic Studio Magic Design for Presentations L&P.pptxNon Text Magic Studio Magic Design for Presentations L&P.pptx
Non Text Magic Studio Magic Design for Presentations L&P.pptx
 
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
 
Call Girls Miyapur 7001305949 all area service COD available Any Time
Call Girls Miyapur 7001305949 all area service COD available Any TimeCall Girls Miyapur 7001305949 all area service COD available Any Time
Call Girls Miyapur 7001305949 all area service COD available Any Time
 
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
 
2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis Usage2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis Usage
 
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCREnjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
 
Call Girls in Mehrauli Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Mehrauli Delhi 💯Call Us 🔝8264348440🔝Call Girls in Mehrauli Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Mehrauli Delhi 💯Call Us 🔝8264348440🔝
 

ICIUM 2011

  • 1. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 1 Third International Conference for Improving Use of Medicines (ICIUM2011): Informed Strategies, Effective Policies, Lasting Solutions Bibliotheca Alexandrina April 10th-14th 2011
  • 2. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 2 WHO Eastern Mediterranean Region 22 countries
  • 3. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 3 Introduction  The diversity in the region hinders any regional generalization.  Contexts are markedly different and so are the priorities.  A low income country – Pakistan – has a sizeable pharmaceutical industrial base.  A highest income country – Qatar – does not have any pharmaceutical company.  A lower middle income country – Jordan – has an FDA with a more than 400 staff.  An upper middle income country – Libya – has almost negligible regulatory capacity Pharmaceutical Context & Priorities
  • 4. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 4 Classification of EMR countries by income (World bank 2009) High-income Upper-middle-income Bahrain Kuwait Oman Qatar Saudi Arabia UAE Lebanon Libya Lower-middle-income Low-income Djibouti Egypt Iran, Islamic Republic Iraq Jordan Morocco Pakistan Palestine Sudan Syrian Arab Republic Tunisia Afghanistan Somalia Yemen
  • 5. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 5 Analytical Matrix W M S Medicine Policy Access Quality - Regulation Rational Use Pharmaceutical Context & Priorities Low Income Countries Lower M Income Countries Upper M Income Countries High Income Countries
  • 6. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 6 Expenditure on medicines from 9 NHA studies in the Region ■ 40% of total health expenditure is on medicines ■ Up to 30% of the budget of ministries of health is spent on medicines ■ Out-of-pocket expenditure is high  Egypt: 53% of all medicines are purchased directly by households  Morocco: 74% Pharmaceutical Context & Priorities
  • 7. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 7 ICIUM Conferences Goals: •Assemble the state-of-the-art knowledge about ways to improve medicines use and health, especially for the most vulnerable populations •Recommend evidence-based strategies for improving use at different levels in the health care system •Identify ways to monitor and evaluate policy impacts •Develop a research agenda to further knowledge about how to improve medicines use
  • 8. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 8 ICIUM conferences are unique  They focus on use of medicines in low and middle income countries  They are highly interactive  They produce actionable results  ICIUM 1997 and 2004 proceedings available at www.icium.org
  • 9. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 9 Partners Supporting ICIUM 2011 •International Network for Rational Use of Drugs •World Health Organization •Eastern Mediterranean Regional Office •Department of Essential Medicines and Pharmaceutical Policies •Harvard Medical School and Boston University School of Public Health: WHO Collaborating Center in Pharmaceutical Policy •Karloniska Institute, Division of Global Health •Management Sciences for Health, Strengthening Pharmaceutical Systems •University of Alexandria •Bibliotheca Alexandrina
  • 10. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 10 Conference Structure: Focus Areas  Conference discussions will focus on each on the following levels in health care systems where changes to improve medicines use take place: Global National Institutional and Individual (health care providers and consumers, including community systems)
  • 11. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 11 Conference Structure: Topic Track Objectives •To cover major areas of clinical and programmatic interest related to pharmaceuticals in low and middle income countries • To encourage cross-fertilization of ideas by having participants from different topic areas
  • 12. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 12 Conference Structure: Provisional Topic Tracks  Access (policy, regulation, governance)  HIV/AIDS, TB  Malaria  Maternal and child health (IMCI, pediatric medicines)  Chronic care (diabetes, hypertension, mental health, information technology for adherence)  Drug resistance (surveillance, containment strategies, drug development)  Economics, financing, insurance systems (cost, affordability, incentives, medicines coverage, policy options, impacts)
  • 13. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 13 ICIUM 2011 Participants  Each of the 500 or so participant of ICIUM2011 will be expected to play an active role in the conference.  Those with submitted abstracts are much more likely to be accepted.  ICIUM 2004 had 472 participants from 70 countries. There were 299 presentations and 326 posters.
  • 14. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 14 ICIUM 2011 Registration and Abstract Submission  Details of how to register and how to submit abstracts are posted on the ICIUM 2011 website www.icium.org  Abstracts must be submitted by 7 December 2010.  Each abstract will be peer reviewed. If improvements are needed authors will be mentored.
  • 15. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 15
  • 16. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 16 Thank you See you April 10th-14th 2011 in the Bibliotheca Alexandria Watch www.icium.org for more information